These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 19080430)
1. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus]. Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430 [TBL] [Abstract][Full Text] [Related]
3. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Brundula V; Rivas LJ; Blasini AM; París M; Salazar S; Stekman IL; Rodríguez MA Arthritis Rheum; 1999 Sep; 42(9):1908-16. PubMed ID: 10513807 [TBL] [Abstract][Full Text] [Related]
4. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics. Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730 [TBL] [Abstract][Full Text] [Related]
5. The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Wang H; Xu J; Ji X; Yang X; Sun K; Liu X; Shen Y Cell Immunol; 2005 Jun; 235(2):117-21. PubMed ID: 16226734 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Yang JH; Zhang J; Cai Q; Zhao DB; Wang J; Guo PE; Liu L; Han XH; Shen Q Rheumatology (Oxford); 2005 Oct; 44(10):1245-54. PubMed ID: 15987711 [TBL] [Abstract][Full Text] [Related]
7. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus. Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657 [TBL] [Abstract][Full Text] [Related]
8. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187 [TBL] [Abstract][Full Text] [Related]
9. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891 [TBL] [Abstract][Full Text] [Related]
10. Increased ubiquitination and reduced expression of LCK in T lymphocytes from patients with systemic lupus erythematosus. Jury EC; Kabouridis PS; Abba A; Mageed RA; Isenberg DA Arthritis Rheum; 2003 May; 48(5):1343-54. PubMed ID: 12746907 [TBL] [Abstract][Full Text] [Related]
11. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Dhir V; Singh AP; Aggarwal A; Naik S; Misra R Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102 [TBL] [Abstract][Full Text] [Related]
12. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus. Mellor-Pita S; Citores MJ; Castejon R; Yebra-Bango M; Tutor-Ureta P; Rosado S; Andreu JL; Vargas JA Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277 [TBL] [Abstract][Full Text] [Related]
13. TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. Vassilopoulos D; Kovacs B; Tsokos GC J Immunol; 1995 Aug; 155(4):2269-81. PubMed ID: 7636273 [TBL] [Abstract][Full Text] [Related]
14. Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus. Nakayamada S; Saito K; Nakano K; Tanaka Y Arthritis Rheum; 2007 May; 56(5):1559-68. PubMed ID: 17469136 [TBL] [Abstract][Full Text] [Related]
15. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. Murakawa Y; Takada S; Ueda Y; Suzuki N; Hoshino T; Sakane T J Immunol; 1985 Jan; 134(1):187-95. PubMed ID: 3917275 [TBL] [Abstract][Full Text] [Related]
16. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258 [TBL] [Abstract][Full Text] [Related]
17. Enhanced phosphoinositide 3-kinase δ activity is a frequent event in systemic lupus erythematosus that confers resistance to activation-induced T cell death. Suárez-Fueyo A; Barber DF; Martínez-Ara J; Zea-Mendoza AC; Carrera AC J Immunol; 2011 Sep; 187(5):2376-85. PubMed ID: 21810603 [TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus]. Yang JH; Shen Q; Zhao DB; Cai Q; Han XH Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508 [TBL] [Abstract][Full Text] [Related]
19. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus]. Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835 [TBL] [Abstract][Full Text] [Related]
20. Increased spontaneous but decreased mitogen-stimulated expression and excretion of interleukin 18 by mononuclear cells in patients with active systemic lupus erythematosus. Lee HT; Chen WS; Sun KH; Chou CT; Tsai CY J Rheumatol; 2009 Sep; 36(9):1910-6. PubMed ID: 19605669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]